-
1
-
-
0037467089
-
Resveratrol content of palomino fino grapes: influence of vintage and fungal infection
-
Roldan A., Palacios V., Caro I., and Perez L. Resveratrol content of palomino fino grapes: influence of vintage and fungal infection. J Agric Food Chem 51 (2003) 1464-1468
-
(2003)
J Agric Food Chem
, vol.51
, pp. 1464-1468
-
-
Roldan, A.1
Palacios, V.2
Caro, I.3
Perez, L.4
-
2
-
-
0031839670
-
Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'?
-
Kopp P. Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'?. Eur J Endocrinol 138 (1998) 619-620
-
(1998)
Eur J Endocrinol
, vol.138
, pp. 619-620
-
-
Kopp, P.1
-
3
-
-
0032965146
-
Trans-resveratrol content in commercial peanuts and peanut products
-
Sobolev V.S., and Cole R.J. Trans-resveratrol content in commercial peanuts and peanut products. J Agric Food Chem 47 (1999) 1435-1439
-
(1999)
J Agric Food Chem
, vol.47
, pp. 1435-1439
-
-
Sobolev, V.S.1
Cole, R.J.2
-
4
-
-
51349132313
-
Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives
-
Kundu J.K., and Surh Y.J. Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. Cancer Lett 269 (2008) 243-261
-
(2008)
Cancer Lett
, vol.269
, pp. 243-261
-
-
Kundu, J.K.1
Surh, Y.J.2
-
5
-
-
69049109766
-
Resveratrol and chemoprevention
-
Goswami S.K., and Das D.K. Resveratrol and chemoprevention. Cancer Lett 284 (2009) 1-6
-
(2009)
Cancer Lett
, vol.284
, pp. 1-6
-
-
Goswami, S.K.1
Das, D.K.2
-
6
-
-
67650297506
-
Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials
-
Bishayee A. Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials. Cancer Prev Res 2 (2009) 409-418
-
(2009)
Cancer Prev Res
, vol.2
, pp. 409-418
-
-
Bishayee, A.1
-
7
-
-
0034741239
-
Resveratrol inhibits human breast cancer cells growth and may mitigate the effect of linoleic acid, a potent breast cancer cell stimulator
-
Nakagawa H., Kiyozuka Y., Uemura Y., et al. Resveratrol inhibits human breast cancer cells growth and may mitigate the effect of linoleic acid, a potent breast cancer cell stimulator. J Cancer Res Clin Oncol 127 (2001) 258-264
-
(2001)
J Cancer Res Clin Oncol
, vol.127
, pp. 258-264
-
-
Nakagawa, H.1
Kiyozuka, Y.2
Uemura, Y.3
-
8
-
-
34547447079
-
Resveratrol-induced growth inhibition in MDA-MB-231 breast cancer cells is associated with mitogen-activated protein kinase signaling and protein translation
-
Alkhalaf M. Resveratrol-induced growth inhibition in MDA-MB-231 breast cancer cells is associated with mitogen-activated protein kinase signaling and protein translation. Eur J Cancer Prev 16 (2007) 334-341
-
(2007)
Eur J Cancer Prev
, vol.16
, pp. 334-341
-
-
Alkhalaf, M.1
-
9
-
-
1642576201
-
Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol
-
Fulda S., and Debatin K.M. Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol. Cancer Res 64 (2004) 337-346
-
(2004)
Cancer Res
, vol.64
, pp. 337-346
-
-
Fulda, S.1
Debatin, K.M.2
-
10
-
-
35648975568
-
Resveratrol sensitizes androgen independent prostate cancer cells to death-receptor mediated apoptosis through multiple mechanisms
-
Gill C., Walsh S.E., Morrissey C., Fitzpatrick J.M., and Watson R.W.G. Resveratrol sensitizes androgen independent prostate cancer cells to death-receptor mediated apoptosis through multiple mechanisms. Prostate 67 (2007) 1641-1653
-
(2007)
Prostate
, vol.67
, pp. 1641-1653
-
-
Gill, C.1
Walsh, S.E.2
Morrissey, C.3
Fitzpatrick, J.M.4
Watson, R.W.G.5
-
11
-
-
4644327128
-
Sensitization for anticancer drug-induced apoptosis by the chemopreventive agent resveratrol
-
Fulda S., and Debatin K.M. Sensitization for anticancer drug-induced apoptosis by the chemopreventive agent resveratrol. Oncogene 23 (2004) 6702-6711
-
(2004)
Oncogene
, vol.23
, pp. 6702-6711
-
-
Fulda, S.1
Debatin, K.M.2
-
12
-
-
69549097739
-
Induction of a reversible, non-cytotoxic S-phase delay by resveratrol: implications for a mechanism of lifespan prolongation and cancer protection
-
Zhou R., Fukui M., Choi H.J., and Zhu B.T. Induction of a reversible, non-cytotoxic S-phase delay by resveratrol: implications for a mechanism of lifespan prolongation and cancer protection. Br J Pharmacol 158 (2009) 462-474
-
(2009)
Br J Pharmacol
, vol.158
, pp. 462-474
-
-
Zhou, R.1
Fukui, M.2
Choi, H.J.3
Zhu, B.T.4
-
13
-
-
0035866404
-
Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinase and p38 kinase
-
She Q.B., Bode A.M., Ma W.Y., Chen N.Y., and Dong Z. Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinase and p38 kinase. Cancer Res 61 (2001) 1604-1610
-
(2001)
Cancer Res
, vol.61
, pp. 1604-1610
-
-
She, Q.B.1
Bode, A.M.2
Ma, W.Y.3
Chen, N.Y.4
Dong, Z.5
-
14
-
-
13444302910
-
Resveratrol induces FasL-related apoptosis through Cdc42 activation of ASK1/JNK-dependent signaling pathway in human keukemia HL-60 cells
-
Su J.L., Lin M.T., Hong C.C., et al. Resveratrol induces FasL-related apoptosis through Cdc42 activation of ASK1/JNK-dependent signaling pathway in human keukemia HL-60 cells. Carcinogenesis 26 (2005) 1-10
-
(2005)
Carcinogenesis
, vol.26
, pp. 1-10
-
-
Su, J.L.1
Lin, M.T.2
Hong, C.C.3
-
15
-
-
33745089904
-
Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells in mediated via modulation of phosphatidilinositol 3′-kinase/Akt pathway and Bcl-2 family proteins
-
Aziz M.H., Nihal M., Fu V.X., Jarrard D.F., and Ahmad N. Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells in mediated via modulation of phosphatidilinositol 3′-kinase/Akt pathway and Bcl-2 family proteins. Mol Cancer Ther 5 (2006) 1335-1341
-
(2006)
Mol Cancer Ther
, vol.5
, pp. 1335-1341
-
-
Aziz, M.H.1
Nihal, M.2
Fu, V.X.3
Jarrard, D.F.4
Ahmad, N.5
-
16
-
-
0036220516
-
Involvement of c-jun NH2-terminal kinases in resveratrol-induced activation of p53 and apoptosis
-
She Q.B., Huang C., Zhang Y., and Dong Z. Involvement of c-jun NH2-terminal kinases in resveratrol-induced activation of p53 and apoptosis. Mol Carcinogen 33 (2002) 244-250
-
(2002)
Mol Carcinogen
, vol.33
, pp. 244-250
-
-
She, Q.B.1
Huang, C.2
Zhang, Y.3
Dong, Z.4
-
17
-
-
1642556763
-
Resveratrol-induced autophagocytosis in ovarian cancer cells
-
Opipari Jr. A.W., Tan L., Boitano A.E., Sorenson D.R., Aurora A., and Liu J.R. Resveratrol-induced autophagocytosis in ovarian cancer cells. Cancer Res 64 (2004) 696-703
-
(2004)
Cancer Res
, vol.64
, pp. 696-703
-
-
Opipari Jr., A.W.1
Tan, L.2
Boitano, A.E.3
Sorenson, D.R.4
Aurora, A.5
Liu, J.R.6
-
18
-
-
17644397025
-
Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl-2 and NF-kappaB
-
Pozo-Guisado E., Merino J.M., Mulero-Navarro S., et al. Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl-2 and NF-kappaB. Int J Cancer 115 (2005) 74-84
-
(2005)
Int J Cancer
, vol.115
, pp. 74-84
-
-
Pozo-Guisado, E.1
Merino, J.M.2
Mulero-Navarro, S.3
-
19
-
-
33947219035
-
Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines
-
Benitez D.A., Pozo-Guisado E., Alvarez-Barrientos A., Fernandez-Salguero P.M., and Castellón E.A. Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines. J Androl 28 (2007) 282-293
-
(2007)
J Androl
, vol.28
, pp. 282-293
-
-
Benitez, D.A.1
Pozo-Guisado, E.2
Alvarez-Barrientos, A.3
Fernandez-Salguero, P.M.4
Castellón, E.A.5
-
20
-
-
0029328641
-
Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway
-
Woods C.M., Zhu J., McQueney P.A., Bollag D., and Lazarides E. Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway. Mol Med 1 (1995) 506-526
-
(1995)
Mol Med
, vol.1
, pp. 506-526
-
-
Woods, C.M.1
Zhu, J.2
McQueney, P.A.3
Bollag, D.4
Lazarides, E.5
-
21
-
-
0345305212
-
Combined effects o resveratrol and paclitaxel on lung cancer cells
-
Kubota T., Uemura Y., Kobayashi M., and Taguchi H. Combined effects o resveratrol and paclitaxel on lung cancer cells. Anticancer Res 23 (2003) 4039-4046
-
(2003)
Anticancer Res
, vol.23
, pp. 4039-4046
-
-
Kubota, T.1
Uemura, Y.2
Kobayashi, M.3
Taguchi, H.4
-
22
-
-
4444274529
-
Resveratrol modifies the expression o apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis
-
Jazirehi A.R., and Bonavida B. Resveratrol modifies the expression o apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis. Mol Cancer Ther 3 (2004) 71-84
-
(2004)
Mol Cancer Ther
, vol.3
, pp. 71-84
-
-
Jazirehi, A.R.1
Bonavida, B.2
-
23
-
-
33646517942
-
Accumulation of hydrogen peroxide is an early and crucial step for paclitaxel-induced cancer cell death both in vitro and in vivo
-
Alexandre J., Batteux F., Nicco C., et al. Accumulation of hydrogen peroxide is an early and crucial step for paclitaxel-induced cancer cell death both in vitro and in vivo. Int J Cancer 119 (2006) 41-48
-
(2006)
Int J Cancer
, vol.119
, pp. 41-48
-
-
Alexandre, J.1
Batteux, F.2
Nicco, C.3
-
24
-
-
34248582844
-
Novel action of paclitaxel against cancer cells: bystander effect mediated by reactive oxygen species
-
Alexandre J., Hu Y., Lu W., Pelicano H., and Huang P. Novel action of paclitaxel against cancer cells: bystander effect mediated by reactive oxygen species. Cancer Res 67 (2007) 3512-3517
-
(2007)
Cancer Res
, vol.67
, pp. 3512-3517
-
-
Alexandre, J.1
Hu, Y.2
Lu, W.3
Pelicano, H.4
Huang, P.5
-
25
-
-
77953288471
-
Mechanism for the protective effect of resveratrol against glutamate-induced neuronal death in HT22 cells
-
Fukui M., Choi H.J., and Zhu B.T. Mechanism for the protective effect of resveratrol against glutamate-induced neuronal death in HT22 cells. Free Radical Biol Med (2010)
-
(2010)
Free Radical Biol Med
-
-
Fukui, M.1
Choi, H.J.2
Zhu, B.T.3
-
26
-
-
0037434841
-
Identification of a novel Bcl-xL phosphorylation site regulating the sensitivity of taxol- or 2-methoxyestradiol-induced apoptosis
-
Basu A., and Haldar S. Identification of a novel Bcl-xL phosphorylation site regulating the sensitivity of taxol- or 2-methoxyestradiol-induced apoptosis. FEBS Lett 538 (2003) 41-47
-
(2003)
FEBS Lett
, vol.538
, pp. 41-47
-
-
Basu, A.1
Haldar, S.2
-
27
-
-
58849135484
-
Mechanism of 2-methoxyestradiol-induced apoptosis and growth arrest in human breast cancer cells
-
Fukui M., and Zhu B.T. Mechanism of 2-methoxyestradiol-induced apoptosis and growth arrest in human breast cancer cells. Mol Carcinog 48 (2009) 66-78
-
(2009)
Mol Carcinog
, vol.48
, pp. 66-78
-
-
Fukui, M.1
Zhu, B.T.2
-
28
-
-
24944486664
-
Resistance to paclitaxel is proportional to cellular total antioxidant capacity
-
Ramanathan B., Jan K.Y., Chen C.H., Hour T.C., Yu H.J., and Pu Y.S. Resistance to paclitaxel is proportional to cellular total antioxidant capacity. Cancer Res 65 (2005) 8455-8460
-
(2005)
Cancer Res
, vol.65
, pp. 8455-8460
-
-
Ramanathan, B.1
Jan, K.Y.2
Chen, C.H.3
Hour, T.C.4
Yu, H.J.5
Pu, Y.S.6
-
29
-
-
14444281569
-
Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways
-
Ichijo H., Nishida E., Irie K., et al. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275 (1997) 90-94
-
(1997)
Science
, vol.275
, pp. 90-94
-
-
Ichijo, H.1
Nishida, E.2
Irie, K.3
-
30
-
-
0032080283
-
Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1
-
Saitoh M., Nishitoh H., Fujii M., et al. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 17 (1998) 2596-2606
-
(1998)
EMBO J
, vol.17
, pp. 2596-2606
-
-
Saitoh, M.1
Nishitoh, H.2
Fujii, M.3
-
31
-
-
0022600388
-
The neu oncogene encodes an epidermal growth factor receptor-related protein
-
Bargmann C.I., Hung M.C., and Weinberg R.A. The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature 319 (1986) 226-230
-
(1986)
Nature
, vol.319
, pp. 226-230
-
-
Bargmann, C.I.1
Hung, M.C.2
Weinberg, R.A.3
-
32
-
-
37049183697
-
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene
-
Slamon D.J., Clark G.M., Wong S.G., Levin W.J., Ullrich A., and McGuire W.L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235 (1987) 177-182
-
(1987)
Science
, vol.235
, pp. 177-182
-
-
Slamon, D.J.1
Clark, G.M.2
Wong, S.G.3
Levin, W.J.4
Ullrich, A.5
McGuire, W.L.6
-
33
-
-
0024337144
-
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
-
Slamon D.J., Godolphin W., Jones L.A., et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244 (1989) 707-712
-
(1989)
Science
, vol.244
, pp. 707-712
-
-
Slamon, D.J.1
Godolphin, W.2
Jones, L.A.3
-
34
-
-
0033545371
-
Growth inhibition of breast cancer cells by Grb2 downregulation is correlated with inactivation of mitogen-activated protein kinase in EGFR, but not in ErbB2, cells
-
Tari A.M., Hung M.C., Li K., and Lopez-Berestein G. Growth inhibition of breast cancer cells by Grb2 downregulation is correlated with inactivation of mitogen-activated protein kinase in EGFR, but not in ErbB2, cells. Oncogene 18 (1999) 1325-1332
-
(1999)
Oncogene
, vol.18
, pp. 1325-1332
-
-
Tari, A.M.1
Hung, M.C.2
Li, K.3
Lopez-Berestein, G.4
-
35
-
-
0242437954
-
HER2/neu reduces the apoptotic effects of N-(4-hydroxyphenyl)retinamide (4-HPR) in breast cancer cells by decreasing nitric oxide production
-
Simeone A.M., Broemeling L.D., Rosenblum J., and Tari A.M. HER2/neu reduces the apoptotic effects of N-(4-hydroxyphenyl)retinamide (4-HPR) in breast cancer cells by decreasing nitric oxide production. Oncogene 22 (2003) 6739-6747
-
(2003)
Oncogene
, vol.22
, pp. 6739-6747
-
-
Simeone, A.M.1
Broemeling, L.D.2
Rosenblum, J.3
Tari, A.M.4
-
36
-
-
0036184567
-
Expression profile of tyrosine kinases in breast cancer
-
Meric F., Lee W.P., Sahin A., et al. Expression profile of tyrosine kinases in breast cancer. Clin Cancer Res 8 (2002) 361-367
-
(2002)
Clin Cancer Res
, vol.8
, pp. 361-367
-
-
Meric, F.1
Lee, W.P.2
Sahin, A.3
-
37
-
-
0034780459
-
Inhibitory effects of the combination of HER-2 antisense oligonucleotide and chemotherapeutic agents used for the treatment of human breast cancer
-
Rait A.S., Pirollo K.F., Rait V., et al. Inhibitory effects of the combination of HER-2 antisense oligonucleotide and chemotherapeutic agents used for the treatment of human breast cancer. Cancer Gene Ther 8 (2001) 728-739
-
(2001)
Cancer Gene Ther
, vol.8
, pp. 728-739
-
-
Rait, A.S.1
Pirollo, K.F.2
Rait, V.3
-
38
-
-
0032214980
-
Overexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21Cip1, which inhibits p34Cdc2 kinase
-
Yu D., Jing T., Liu B., et al. Overexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21Cip1, which inhibits p34Cdc2 kinase. Mol Cell 2 (1998) 581-591
-
(1998)
Mol Cell
, vol.2
, pp. 581-591
-
-
Yu, D.1
Jing, T.2
Liu, B.3
-
39
-
-
52049084361
-
Synergistic growth inhibition by 9-cis-retinoic acid plus trastuzumab in human hepatocellular carcinoma cells
-
Tatebe H., Shimizu M., Shirakami Y., Tsurumi H., and Moriwaki H. Synergistic growth inhibition by 9-cis-retinoic acid plus trastuzumab in human hepatocellular carcinoma cells. Clin Cancer Res 14 (2008) 2806-2812
-
(2008)
Clin Cancer Res
, vol.14
, pp. 2806-2812
-
-
Tatebe, H.1
Shimizu, M.2
Shirakami, Y.3
Tsurumi, H.4
Moriwaki, H.5
-
40
-
-
0034660857
-
Down-regulation of neu/HER-2 by interferon-gamma in prostate cancer cells
-
Kominsky S.L., Hobeika A.C., Lake F.A., Torres B.A., and Johnson H.M. Down-regulation of neu/HER-2 by interferon-gamma in prostate cancer cells. Cancer Res 15 (2000) 3904-3908
-
(2000)
Cancer Res
, vol.15
, pp. 3904-3908
-
-
Kominsky, S.L.1
Hobeika, A.C.2
Lake, F.A.3
Torres, B.A.4
Johnson, H.M.5
-
41
-
-
0344873744
-
Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines
-
DeArmond D., Brattain M.G., Jessup J.M., et al. Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines. Oncogene 22 (2003) 7781-7795
-
(2003)
Oncogene
, vol.22
, pp. 7781-7795
-
-
DeArmond, D.1
Brattain, M.G.2
Jessup, J.M.3
-
42
-
-
0018236173
-
Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization
-
Cailleau R., Olivé M., and Cruciger Q.V. Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro 14 (1978) 911-915
-
(1978)
In Vitro
, vol.14
, pp. 911-915
-
-
Cailleau, R.1
Olivé, M.2
Cruciger, Q.V.3
-
43
-
-
67650456890
-
MDA-MB-435 and M14 cell lines: identical but not M14 melanoma?
-
Chambers A.F. MDA-MB-435 and M14 cell lines: identical but not M14 melanoma?. Cancer Res 69 (2009) 5292-5293
-
(2009)
Cancer Res
, vol.69
, pp. 5292-5293
-
-
Chambers, A.F.1
-
44
-
-
0034050902
-
Systematic variation in gene expression patterns in human cancer cell lines
-
Ross D.T., Scherf U., Eisen M.B., et al. Systematic variation in gene expression patterns in human cancer cell lines. Nature Genet 24 (2000) 227-235
-
(2000)
Nature Genet
, vol.24
, pp. 227-235
-
-
Ross, D.T.1
Scherf, U.2
Eisen, M.B.3
-
45
-
-
2442701892
-
Lineage infidelity of MDA-MB-435 cells: expression of melanocyte proteins in a breast cancer cell line
-
Sellappan S., Grijalva R., Zhou X., et al. Lineage infidelity of MDA-MB-435 cells: expression of melanocyte proteins in a breast cancer cell line. Cancer Res 15 (2004) 3479-3485
-
(2004)
Cancer Res
, vol.15
, pp. 3479-3485
-
-
Sellappan, S.1
Grijalva, R.2
Zhou, X.3
-
46
-
-
0036798578
-
Further evidence to support the melanocytic origin of MDA-MB-435
-
Ellison G., Klinowska T., Westwood R.F., et al. Further evidence to support the melanocytic origin of MDA-MB-435. Mol Pathol 55 (2002) 294-299
-
(2002)
Mol Pathol
, vol.55
, pp. 294-299
-
-
Ellison, G.1
Klinowska, T.2
Westwood, R.F.3
|